Literature DB >> 11115364

Development of a condemned mucosa syndrome and pathogenesis of human papillomavirus-associated upper aerodigestive tract and uterine cervical tumors.

M R Pillai1, M K Nair.   

Abstract

High-risk human papillomaviruses (HPVs) have been shown to be involved in the pathogenesis of many squamous carcinomas, particularly those of the uterine cervix. A number of random studies have also reported association of high-risk HPV subtypes with cancers of the oral cavity, larynx, hypopharynx, and esophagus. The roles of other molecular factors involved during HPV infection in these tumors still remain unclear. Recent findings from our laboratories have suggested possible mechanisms associated with HPV-mediated carcinogenesis. Both p53 mutation-dependent and mutation-independent pathways may be associated with HPV-mediated carcinogenesis, the former mainly in upper aerodigestive tract tumors (UADT) and the latter in cervical tumors. In cervical tumors, inactivation of the p53 tumor suppressor protein by the E6 gene product of high-risk HPVs and mutation of the p53 gene in UADT is associated with alterations in the apoptotic regulatory bcl-2 and bax genes, leading to downregulation of programmed cell death (PCD) and increased cell proliferation. HPV infection is also associated with increased tissue angiogenesis and activation of telomerase. Altered kinetics of telomere fragments is evident in HPV-infected tissue. We therefore believe that the combined manifestations of all these factors may contribute to development of a "condemned mucosa syndrome" facilitating development UADT and cervical cancers. A distinct step in the pathogenesis of both types of tumors may only be in the mode of p53 inactivation, whereas all other events appear to be strongly correlated to the presence of HPV. The development and validation of such a molecular model has significant clinical priority. It can be used to identify target populations or individuals for intervention, to monitor effects of intervention, and to determine which individuals or groups are at increased risk of developing cancer. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115364     DOI: 10.1006/exmp.2000.2335

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  9 in total

1.  Improving palliative treatment of patients with non-operable cancer of the oesophagus: training doctors and nurses in the use of self-expanding metal stents (SEMS) in Malawi.

Authors:  A Thumbs; L Vigna; J Bates; L Fullerton; A L Kushner
Journal:  Malawi Med J       Date:  2012-03       Impact factor: 0.875

2.  Human papillomavirus in esophageal squamous cell carcinoma in Colombia and Chile.

Authors:  Andres Castillo; Francisco Aguayo; Chihaya Koriyama; Miyerlandi Torres; Edwin Carrascal; Alejandro Corvalan; Juan-P Roblero; Cecilia Naquira; Mariana Palma; Claudia Backhouse; Jorge Argandona; Tetsuhiko Itoh; Karem Shuyama; Yoshito Eizuru; Suminori Akiba
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

3.  Human papilloma virus and esophageal carcinoma in a Latin-American region.

Authors:  Roberto Herrera-Goepfert; Marcela Lizano; Suminori Akiba; Adela Carrillo-García; Mauricio Becker-D'Acosta
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

Review 4.  Human papilloma virus in head and neck cancers-role and relevance in clinical management.

Authors:  Vijayalakshmi Ramshankar; Arvind Krishnamurthy
Journal:  Indian J Surg Oncol       Date:  2012-12-14

Review 5.  HPV infections and oesophageal cancer.

Authors:  K J Syrjänen
Journal:  J Clin Pathol       Date:  2002-10       Impact factor: 3.411

Review 6.  Human Papilloma Virus (HPV) Induced Head & Neck Squamous Cell Carcinoma: A Comprehensive Retrospect.

Authors:  Roquaiya Nishat; Shyam Sundar Behura; Sujatha Ramachandra; Harish Kumar; Alokenath Bandyopadhyay
Journal:  J Clin Diagn Res       Date:  2015-06-01

7.  Lung Cancer and Human Papilloma Viruses (HPVs): Examining the Molecular Evidence.

Authors:  Priya R Prabhu; D Jayalekshmi; M Radhakrishna Pillai
Journal:  J Oncol       Date:  2012-01-26       Impact factor: 4.375

8.  Human papillomavirus up-regulates MMP-2 and MMP-9 expression and activity by inducing interleukin-8 in lung adenocarcinomas.

Authors:  Ming-Yuh Shiau; Li-Ching Fan; Shun-Chun Yang; Chang-Hui Tsao; Huei Lee; Ya-Wen Cheng; Li-Chuan Lai; Yih-Hsin Chang
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

9.  Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China.

Authors:  K Shuyama; A Castillo; F Aguayo; Q Sun; N Khan; C Koriyama; S Akiba
Journal:  Br J Cancer       Date:  2007-04-24       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.